In her work for Lead Counsel of the Johnson & Johnson Talcum Powder litigation, she worked extensively with leading urogynecologic oncologists to develop the Plaintiff’s liability case and demonstrate the causal link between talc and ovarian cancer. This work was recently the subject of an extensive opinion by MDL Judge Freda Wolfson on April 27, 2020, which found that Plaintiff’s experts’ opinions used reliable methodology and substantially supported by science. Less than three weeks later, Johnson & Johnson announced it would discontinue approximately 100 products containing talcum powder in North America. In August 2022, Johnson & Johnson announced it would stop selling talc-based powder worldwide in 2023. Epidemiological studies have shown that between 2,200-5,000 of new ovarian cancer cases were caused by talcum powder use by women – cases that will never occur in future generations of women and girls.
Breanne’s talents and expertise have been recognized by numerous groups and professional organizations. She has been recognized as a Northern California Super Lawyer Rising Star each year as the founder of BGAN Law, 2018-2020. She is frequently called upon to speak at conferences and continuing education events. Notably, Breanne was tapped to speak at the 40th Annual Meeting of the International Urogynecologic Association in Nice, France, on the controversial topic of transvaginal mesh litigation. An interactive workshop, the presentation represented an important first – bringing the doctors using transvaginal mesh products all over the world an inside look at the litigation and evidence used at various mesh trials and facilitating a productive and novel conversation with attorneys and healthcare providers on the issues surrounding transvaginal mesh.
